C CENYX BIOTECH Logo (WIPO, 04/29/2022)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark C CENYX BIOTECH was filed as Figurative mark on 04/29/2022 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Letters embellished or decorated with a drawing #Series of letters presenting different forms of writing #Series of letters in different dimensions #Three predominant colours
| Trademark form | Figurative mark |
| File reference | 1673833 |
| Register number | 4018274040000 |
| Countries | 
|
| Base trademark |
No. 4018274040000,
January 28, 2022
|
| Application date | April 29, 2022 |
| Expiration date | April 29, 2032 |
Trademark owner
51 bench, Collaborating laboratory 2B,
101, Daehak-ro, Jongno-gu
KR
101, Daehak-ro, Jongno-gu
KR
Trademark representatives
Bethel Bldg. 8F.,
23, Dongsan-ro, Seocho-gu
KR
goods and services
05
Diagnostic reagents for medical or veterinary purposes;
diagnostic preparations for medical or veterinary purposes;
veterinary preparations; radio-isotope markers for
therapeutic or diagnostic use; in vitro diagnostic
preparations for medical purposes; vaccines; contrast media
for use in medical imaging; contrast media for in vivo
imaging; drug delivery agents that facilitate the delivery
of pharmaceutical preparations; pharmaceutical preparations
for the prevention of inflammatory disorders;
non-prescription medicines; radioactive pharmaceutical
preparations for in vivo diagnostics or therapeutic use;
diagnostic agents for medical purposes; biological
preparations for medical or veterinary purposes;
pharmaceuticals; pharmaceutical preparations for the
prevention of disorders of the cardio-vascular system;
pharmaceutical preparations for the treatment of
cardiovascular disease; drug delivery agents; pharmaceutical
preparations for the treatment of inflammatory diseases;
antibodies for medical purposes
42
Conducting clinical trials in the field of cardiovascular
disease; scientific research for medical purposes in the
field of cancerous diseases; pharmaceutical research and
development; clinical research in the field of medicine;
analysis and evaluation of medical product development;
scientific research for medical purposes in the area of
cancerous diseases; scientific research in the field of
pharmacy
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 18, 2023 | 2023/20 Gaz | JP | Rejection |
| April 27, 2023 | 2023/17 Gaz | US | Rejection |
| March 22, 2023 | 2023/12 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 13, 2023 | 2023/13 Gaz | RAW: Limitation | |
| February 13, 2023 | 2023/7 Gaz | CN | Rejection |
| January 26, 2023 | 2023/6 Gaz | EM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| January 25, 2023 | 2023/4 Gaz | GB | Rejection |
| October 12, 2022 | 2022/43 Gaz | RAW: Limitation | |
| August 25, 2022 | 2022/39 Gaz | AU | Rejection |
| July 21, 2022 | 2022/30 Gaz | EM | Rejection |
| April 29, 2022 | 2022/27 Gaz | KR | Registration |
ID: 141673833